NYSE:RMD
Resmed Inc.
Resmed Inc.'s revenue grew 9.9% in fiscal 2026 to $5.7B while operating margin rose to 33.4%, its highest in 10 years. Free cash flow was $1.6B, 29.2% of revenue, and the diluted share count fell 0.9%.Summary generated from Resmed Inc.'s SEC filings. Latest annual report filed Aug 13, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$5.7B
Revenue growth+9.9%
Revenue, 5-yr CAGR+12.1%
Gross margin61.1%
Operating margin33.4%
Net margin26.9%
ROIC26.7%
Return on equity24.3%
Debt / equity0.10
Free cash flow$1.6B
FCF margin29.2%
Share count change−0.9%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 3,578 | 4,223 | 4,685 | 5,146 | 5,653 |
| Operating income | 1,000 | 1,132 | 1,320 | 1,685 | 1,887 |
| Net income | 779 | 898 | 1,021 | 1,401 | 1,523 |
| Free cash flow | 216 | 574 | 1,302 | 1,662 | 1,650 |
Recent filings
- 4Insider transaction report
Oct 8, 2026 - DEF 14AProxy statement
Oct 1, 2026 - 4Insider transaction report
Oct 1, 2026 - 8-KOther events
Sep 1, 2026 - 8-KChange in auditor
Aug 17, 2026 - 10-KAnnual report for the fiscal year ended Jun 30, 2026
Aug 13, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KResults of operations and financial condition
Jul 7, 2026